G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy

Ozelius, Laurie J.; Foroud, Tatiana; May, Susanne; Senthil, Geetha; Sandroni, Paola; Low, Phillip A.; Reich, Stephen; Colcher, Amy; Stern, Matthew B.; Ondo, William G.; Jankovic, Joseph; Huang, Neng; Tanner, Caroline M.; Novak, Peter; Gilman, Sid; Marshall, Frederick J.; Wooten, G. Frederick; Chelimsky, Thomas C.; Shults, Clifford W.

2007-03-15

Citation: Ozelius, Laurie J.; Foroud, Tatiana; May, Susanne; Senthil, Geetha; Sandroni, Paola; Low, Phillip A.; Reich, Stephen; Colcher, Amy; Stern, Matthew B.; Ondo, William G.; Jankovic, Joseph; Huang, Neng; Tanner, Caroline M.; Novak, Peter; Gilman, Sid; Marshall, Frederick J.; Wooten, G. Frederick; Chelimsky, Thomas C.; Shults, Clifford W. (2007)."G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy." Movement Disorders 22(4): 546-549. <http://hdl.handle.net/2027.42/56014>

Abstract: Multiple system atrophy (MSA) is characterized clinically by Parkinsonism, cerebellar dysfunction, and autonomic impairment. Multiple mutations in the LRRK2 gene are associated with parkinsonian disorders, and the most common one, the G2019S mutation, has been found in ∼1% of sporadic cases of Parkinsonism. In a well-characterized cohort of 136 subjects with probable MSA and 110 neurologically evaluated control subjects, none carried the G2019S mutation. We conclude that the G2019S mutation in the LRRK2 gene is unlikely to be associated with MSA. © 2007 Movement Disorder Society

ISSN: 0885-3185, 1531-8257

DOIs: http://dx.doi.org/10.1002/mds.21343

PMID: 17230458

URI: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17230458&dopt=citation

Handle: http://hdl.handle.net/2027.42/56014

Show full item record